鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/09 | 3,595 | 3,710 | 3,595 | 3,700 | +65 | +1.8% | 26,000 |
| 2024/09/06 | 3,645 | 3,645 | 3,620 | 3,635 | -10 | -0.3% | 13,400 |
| 2024/09/05 | 3,630 | 3,695 | 3,630 | 3,645 | -5 | -0.1% | 18,000 |
| 2024/09/04 | 3,655 | 3,690 | 3,615 | 3,650 | -65 | -1.7% | 19,800 |
| 2024/09/03 | 3,645 | 3,715 | 3,645 | 3,715 | +70 | +1.9% | 28,400 |
| 2024/09/02 | 3,690 | 3,715 | 3,605 | 3,645 | -45 | -1.2% | 19,700 |
| 2024/08/30 | 3,720 | 3,735 | 3,660 | 3,690 | ±0 | ±0% | 43,800 |
| 2024/08/29 | 3,630 | 3,705 | 3,630 | 3,690 | +75 | +2.1% | 23,300 |
| 2024/08/28 | 3,545 | 3,645 | 3,545 | 3,615 | +65 | +1.8% | 24,600 |
| 2024/08/27 | 3,495 | 3,555 | 3,475 | 3,550 | +70 | +2% | 19,500 |
| 2024/08/26 | 3,450 | 3,480 | 3,450 | 3,480 | +40 | +1.2% | 9,600 |
| 2024/08/23 | 3,455 | 3,465 | 3,435 | 3,440 | -15 | -0.4% | 17,300 |
| 2024/08/22 | 3,445 | 3,455 | 3,415 | 3,455 | +30 | +0.9% | 9,200 |
| 2024/08/21 | 3,455 | 3,470 | 3,405 | 3,425 | -55 | -1.6% | 14,800 |
| 2024/08/20 | 3,465 | 3,480 | 3,420 | 3,480 | +60 | +1.8% | 6,200 |
| 2024/08/19 | 3,445 | 3,485 | 3,420 | 3,420 | -70 | -2% | 13,900 |
| 2024/08/16 | 3,485 | 3,490 | 3,445 | 3,490 | +35 | +1% | 23,900 |
| 2024/08/15 | 3,470 | 3,475 | 3,430 | 3,455 | -15 | -0.4% | 22,900 |
| 2024/08/14 | 3,500 | 3,500 | 3,445 | 3,470 | -25 | -0.7% | 12,600 |
| 2024/08/13 | 3,415 | 3,495 | 3,415 | 3,495 | +80 | +2.3% | 32,600 |
| 2024/08/09 | 3,450 | 3,450 | 3,375 | 3,415 | +35 | +1% | 29,100 |
| 2024/08/08 | 3,315 | 3,415 | 3,295 | 3,380 | +30 | +0.9% | 45,600 |
| 2024/08/07 | 3,280 | 3,425 | 3,245 | 3,350 | +45 | +1.4% | 28,500 |
| 2024/08/06 | 3,260 | 3,395 | 3,260 | 3,305 | +90 | +2.8% | 48,400 |
| 2024/08/05 | 3,380 | 3,385 | 3,105 | 3,215 | -235 | -6.8% | 90,900 |
| 2024/08/02 | 3,595 | 3,645 | 3,450 | 3,450 | -180 | -5% | 100,200 |
| 2024/08/01 | 3,735 | 3,735 | 3,610 | 3,630 | -115 | -3.1% | 52,200 |
| 2024/07/31 | 3,690 | 3,750 | 3,675 | 3,745 | +30 | +0.8% | 19,400 |
| 2024/07/30 | 3,715 | 3,750 | 3,685 | 3,715 | ±0 | ±0% | 25,700 |
| 2024/07/29 | 3,695 | 3,720 | 3,690 | 3,715 | +55 | +1.5% | 16,900 |
| 2024/07/26 | 3,675 | 3,705 | 3,650 | 3,660 | -15 | -0.4% | 19,200 |
| 2024/07/25 | 3,665 | 3,720 | 3,665 | 3,675 | -20 | -0.5% | 23,400 |
| 2024/07/24 | 3,730 | 3,730 | 3,680 | 3,695 | -25 | -0.7% | 15,800 |
| 2024/07/23 | 3,700 | 3,735 | 3,675 | 3,720 | +45 | +1.2% | 11,900 |
| 2024/07/22 | 3,715 | 3,720 | 3,665 | 3,675 | -55 | -1.5% | 15,000 |
| 2024/07/19 | 3,700 | 3,740 | 3,690 | 3,730 | -20 | -0.5% | 22,200 |
| 2024/07/18 | 3,720 | 3,795 | 3,705 | 3,750 | ±0 | ±0% | 19,500 |
| 2024/07/17 | 3,775 | 3,775 | 3,730 | 3,750 | -5 | -0.1% | 18,200 |
| 2024/07/16 | 3,790 | 3,820 | 3,730 | 3,755 | -60 | -1.6% | 22,500 |
| 2024/07/12 | 3,705 | 3,835 | 3,705 | 3,815 | +85 | +2.3% | 38,900 |
| 2024/07/11 | 3,735 | 3,755 | 3,695 | 3,730 | -5 | -0.1% | 50,800 |
| 2024/07/10 | 3,725 | 3,770 | 3,705 | 3,735 | +10 | +0.3% | 29,300 |
| 2024/07/09 | 3,760 | 3,805 | 3,725 | 3,725 | -35 | -0.9% | 27,600 |
| 2024/07/08 | 3,735 | 3,765 | 3,685 | 3,760 | +25 | +0.7% | 48,400 |
| 2024/07/05 | 3,750 | 3,750 | 3,710 | 3,735 | -15 | -0.4% | 11,500 |
| 2024/07/04 | 3,700 | 3,750 | 3,690 | 3,750 | +40 | +1.1% | 18,900 |
| 2024/07/03 | 3,665 | 3,740 | 3,665 | 3,710 | +40 | +1.1% | 37,700 |
| 2024/07/02 | 3,680 | 3,705 | 3,665 | 3,670 | -20 | -0.5% | 16,400 |
| 2024/07/01 | 3,675 | 3,705 | 3,660 | 3,690 | +15 | +0.4% | 15,500 |
| 2024/06/28 | 3,700 | 3,705 | 3,660 | 3,675 | -25 | -0.7% | 19,100 |
1～
50
件表示中 / 3536件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 370,000円 | +11.1% | +20.6% | 3.24% | 21.67倍 | 0.86倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| ゼリア新薬 | 226,500円 | +9.6% | +17.5% | 2.03% | 12.80倍 | 1.25倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 128,200円 | +197.7% | - | 0.00% | 52.39倍 | 1.67倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ジーエヌアイ | 211,600円 | +52.1% | +23.3% | 0.00% | 15.01倍 | 2.88倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 杏林製薬 | 155,300円 | +3.2% | +4.5% | 3.35% | 17.84倍 | 0.68倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
